Oriol Mitja: Clinical Trials

3 trials sponsored by Oriol Mitja, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 31Withdrawn 1

Follow Oriol Mitja: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea
Combination regimen: Fluoxetine, Prednisolone, Ivermectin, Combination regimen: Albendazole, Vitamin C - SARS-CoV2 Infection, COVID-19
Phase 2 / Phase 3WithdrawnOriol Mitja2022-05-012023-03-09
An Accessible Low-cost Plant Treatment for Cutaneous Ulcers
Topical antiseptic treatment - Yaws; Cutaneous, Cutaneous Ulcer
Phase 2CompletedOriol Mitja1502019-11-012020-09-03
Dual Point-of-care Test for the Diagnosis of Yaws
Yaws
CompletedOriol Mitja7032013-04-012014-11-18

Conditions studied

Yaws (2)  ·  COVID-19 (1)  ·  Disease (1)  ·  Skin Ulcer (1)

Interventions

Ascorbic Acid (1)  ·  Ivermectin (1)  ·  Prednisolone (1)

Countries

Papua New Guinea (2)

Results publications

PMID 25103395